A021502 Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

June 30, 2018
https://clinicaltrials.gov/ct2/show/NCT02912559
Cancer - Gastro/ Colorectal
Principal Investigator: Ding Wang, MD
CANCER, STAGE 3, COLON, COLON CANCER
Accepting Participants